Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 1998

Study Completion Date

February 29, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

carmustine

DRUG

polifeprosan 20 with carmustine implant

PROCEDURE

surgical procedure

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER